2021 Global Drugs of Abuse Testing Market Assessment for 12 Assays--US, Europe, Japan--Supplier Shares and Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers

2021 Global Drugs of Abuse Testing Market Assessment for 12 Assays--US, Europe, Japan--Supplier Shares and Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers

  • April 2021 •
  • Report ID: 6058607 •
  • Format: PDF
2021 Global Drugs of Abuse Testing Market Assessment for 12 Assays--US, Europe, Japan--Supplier Shares and Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers

This unique report provides information and analysis not available from any other published source.

The report is available by section, and can be customized to specific information needs and budget.

This new 318-page report contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.

During the next decade, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

This report is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., five major European countries and Japan; and provides test volume and sales forecasts by country, market segment and individual assay.

Contains 318 pages and 68 tables



Companies Profiled

Competitive Assessments

- Abbott Laboratories
- Agilent Technologies
- Beckman Coulter/Danaher
- bioMerieux
- Bio-Rad
- DiaSorin
- Eiken Chemical
- Fujirebio
- Grifols
- Instrumentation Laboratory/Werfen
- Kyowa Medex
- Ortho-Clinical Diagnostics
- PerkinElmer
- Quest Diagnostics
- Roche
- Siemens Healthineers
- Sysmex
- Thermo Fisher
- Tosoh
- Wako